'Omics' biomarkers associated with chronic low back pain: protocol of a retrospective longitudinal study.

ABSTRACT:

Introduction

Chronic low back pain (CLBP) produces considerable direct costs as well as indirect burdens for society, industry and health systems. CLBP is characterised by heterogeneity, inclusion of several pain syndromes, different underlying molecular pathologies and interaction with psychosocial factors that leads to a range of clinical manifestations. There is still much to understand in the underlying pathological processes and the non-psychosocial factors which account for differences in outcomes. Biomarkers that may be objectively used for diagnosis and personalised, targeted and cost-effective treatment are still lacking. Therefore, any data that may be obtained at the '-omics' level (glycomics, Activomics and genome-wide association studies-GWAS) may be helpful to use as

SUBMITTER: Allegri M 

PROVIDER: S-EPMC5073566 | biostudies-literature | 2016 Oct

REPOSITORIES: biostudies-literature